Fuda Cancer Hospital - India

Fuda Cancer Hospital - India Fuda Cancer Hospital is famous for advance robotics & minimally invasive treatments. Cancer treatment varies from patient to patient.

It is located in Guangzhou (China) & have a consulting clinic and information centre in Mumbai (India). Fuda is committed to providing cancer patients around the world with the best medical care. Fuda Cancer Hospital is considered one of the BEST cancer hospitals in China by patients and is affiliated to Jinan University and Translational Medicine Center of Guangzhou Institute of Biomedicine and Health of Chinese Academy of Sciences. As a tertiary hospital, Fuda operates with international standards and was selected as the National Key Clinical Specialty (Oncology) in 2010. In 2014, Fuda was accredited by the Joint Commission International (JCI), a golden standard of medical service worldwide. Fuda is equipped with 400 beds, 45 VIP rooms and 500 medical staffs to help our patients. Multiple Disciplinary Teams work in Fuda to personalize treatment for every single patient. Those teams include NanoKnife Ablation team (Irreversible Electroporation), Cryosurgical ablation team, cancer micro-vascular intervention team, combined immunotherapy team, and surgical team. Our clinical achievement and academic research are widely accepted by peer doctors and scientific journals. In Fuda, Doctors use more than 20 types of cancer treatment, including those mentioned above, to help our patient LIVE WITH CANCER as long as possible with a quality life. Fuda highly focuses on research and application of advanced clinical procedures and pays tremendous attention on patient care. In the past two decades, Fuda has been active in promoting Minimally Invasive Treatments such as Cryosurgery, NanoKnife, micro-vascular intervention treatment and Brachytherapy. Fuda was the first in China to introduce NanoKnife for clinical use and has accumulated substantial clinical experience. Patients are not just receiving treatment in Fuda, they live a life in Fuda with their family. To date, patients from over 110 countries were treated in Fuda and 50% of them are from South-East Asia, the Middle East, Oceania, Europe and North America. The number of patients treated in Fuda with Minimally Invasive treatments outnumbers any other hospital in the world. Fuda has received various awards in China and abroad for outstanding achievements in treating cancers and has been highly praised by patients worldwide.

06/12/2025

[Minimally invasive treatment] [Brunei-Pancreatic Cancer-Nanoknife]
Seize the "Pancreatic" Vitality : Nanoknife Precisely Destroys Tumors

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in

[Fuda News] [International Gathering]Guangzhou Fuda Cancer Hospital Shines at the “Belt and Road” Global Medical and Hea...
02/12/2025

[Fuda News] [International Gathering]

Guangzhou Fuda Cancer Hospital Shines at the “Belt and Road” Global Medical and Health Summit

From November 27 to 28, 2025, the First “Belt and Road” Global Medical and Health Exchange Conference and the Third “Belt and Road” Exchange Conference for Chinese Universities and Overseas Partners were successfully held in Guangzhou. As one of the representative medical institutions from China, Guangzhou Fuda Cancer Hospital was invited to participate. The event brought together embassy representatives, government officials, university delegates, and leaders of medical organizations from dozens of countries to explore new opportunities for international medical and health cooperation.

As a National Key Clinical Specialty (Oncology) hospital, Guangzhou Fuda Cancer Hospital integrates medical care, teaching, scientific research, and preventive health services. With cutting-edge technologies at its core, it has developed into a modern international oncology hospital. At the conference, Ms. Tan Cuicui, Head of the International Affairs Department, led the delegation in productive discussions with medical and educational institutions from Belt and Road countries. The team highlighted the hospital’s signature minimally invasive techniques, including cryoablation, NanoKnife ablation, vascular interventional therapy, iodine-125 seed implantation, and photodynamic therapy, attracting considerable interest and attention from international attendees.

This conference not only reflects Guangzhou Fuda Cancer Hospital’s active response to the Belt and Road Initiative, but also marks a key step in expanding international cooperation channels, promoting medical resource sharing, and accelerating overseas development. Leveraging this opportunity, the hospital will continue to deepen collaboration and exchange with Belt and Road countries in the field of healthcare, advancing the mutual learning of advanced medical technologies and scientific achievements, enhancing global medical resource integration and optimization, injecting health-driven momentum into the high-quality development of the Belt and Road, and providing high-quality and accessible medical services to people worldwide.

Click to read more patient stories

https://en.fudahospital.com/
📞 Contact us via:
Phone: +91 8850860970
WhatsApp: +91 8850860970
Website: https://fudahospital.in

[Fuda News] [International Conference – NanoKnife]China’s Voice on the Global Stage: President Niu Lizhi Shares NanoKnif...
25/11/2025

[Fuda News] [International Conference – NanoKnife]

China’s Voice on the Global Stage: President Niu Lizhi Shares NanoKnife Achievements, Sparking Active Q&A

At the recent ANGIODYNAMICS INTERNATIONAL LIFE SYMPOSIUM, Dr. Niu Lizhi, President of Guangzhou Fuda Cancer Hospital, traveled to Europe to present to leading experts worldwide the current status of NanoKnife ablation technology in China, as well as China’s clinical experience and outcomes using NanoKnife combined with chemotherapy in treating hilar cholangiocarcinoma. This breakthrough therapy drew strong interest from international participants, prompting an enthusiastic Q&A session.

Hilar cholangiocarcinoma is notoriously difficult to treat due to its complex anatomical location. Tumors often invade major vascular structures, and most patients lose the opportunity for curative surgery by the time of diagnosis. For those with advanced, unresectable disease, traditional treatment options remain limited, and a breakthrough therapy is urgently needed. NanoKnife ablation has emerged as one such breakthrough in addressing this global clinical challenge.

The NanoKnife, also known as Irreversible Electroporation (IRE), is a non-thermal tumor ablation technique. It delivers microsecond high-voltage electrical pulses that create nanoscale pores in cancer cell membranes, inducing apoptosis while preserving nearby vital structures such as blood vessels, nerves, and bile ducts. This makes it particularly suitable for tumors located in anatomically complex regions such as the hepatic hilum, gallbladder and bile ducts, and pancreas.
As one of the earliest hospitals in China to adopt NanoKnife technology, Guangzhou Fuda Cancer Hospital has successfully performed thousands of NanoKnife ablation procedures, ranking among the world’s leading centers. The hospital has also developed a comprehensive treatment system and clinical pathway, enabling the Chinese team to accumulate extensive experience and offer new hope to patients with unresectable hilar cholangiocarcinoma. During the conference, Dr. Niu presented clinical data demonstrating outcomes significantly superior to traditional monotherapies, attracting wide attention from attendees.

NanoKnife is not a stand-alone treatment but a key component of a multidisciplinary approach. The integration of local ablation and systemic therapy is expected to become an important trend in the future management of hilar cholangiocarcinoma. With continuous advancements in China’s medical technology and deepening international collaboration, more innovative Chinese treatment approaches are stepping onto the global stage. Guangzhou Fuda Cancer Hospital will continue to contribute China’s wisdom and strength to the worldwide fight against cancer.

Click to read more patient stories

https://en.fudahospital.com/
📞 Contact us via:
Phone: +91 8850860970
WhatsApp: +91 8850860970
Website: https://fudahospital.in

[Breaking News] [Indonesia – Sudden Carotid Artery Rupture Caused by Right Cervical Spindle Cell Sarcoma]1,000 ml of Blo...
20/11/2025

[Breaking News] [Indonesia – Sudden Carotid Artery Rupture Caused by Right Cervical Spindle Cell Sarcoma]

1,000 ml of Blood Loss, Three Life-Saving Relays, and an 18-Hour Extreme Rescue

At 11 p.m., the lights at Guangzhou Fuda Cancer Hospital were still blazing. A desperate race against death was unfolding—an Indonesian patient suffered a sudden massive hemorrhage after a spindle cell sarcoma in the right neck invaded the carotid artery and ruptured. In an instant, blood spurted out violently. The patient lost nearly 1,000 ml of blood.
A silent life alarm was triggered. In the critical moment, Dr. Jia Xintong and the on-duty nurses became the first line of defense. Without hesitation, they rushed forward and pressed firmly on the bleeding site with their bare hands. That single press lasted one full hour. Every second was a countdown to life; every second was held up by unwavering determination and a sense of sacred duty.

Life-saving efforts could not wait. Relevant departments mobilized instantly and cooperated with precision. Interventional specialist Director Yang Qingfeng and Dr. Qiu Ningning rushed to the hospital from home in the middle of the night to begin the first lifesaving relay—performing emergency embolization to stop the bleeding. In the stillness of the early morning, their expertise and persistence guarded the first glimmer of hope.
The lights in the blood bank also stayed on through the night. Thanks to the blood reserves from the hospital’s fourth voluntary staff donation drive this year, the clinical supply remained secure.
When a specific blood type ran critically low, a driver from the service department volunteered immediately:
“I know the route well. I’ll take it!”
Gripping the steering wheel, he raced through the dark city to deliver the urgently needed blood to the operating floor at top speed. This invisible lifeline was reinforced by every ordinary person making extraordinary efforts.

Meanwhile, Dr. Liu Zhengping and the team in Indonesia stayed awake with their phones in hand, anxiously following the situation in Guangzhou. Cross-border updates, translated in real time, connected the care and expertise of both countries.
After an urgent multidisciplinary evaluation led by President Niu Lizhi, Prof. Zeng Zongyuan, Director Xu Jiongyuan, and external experts, the team decided to implant a covered stent. Like tightly interlocking gears, all departments activated emergency protocols with flawless coordination, opening a seamless green channel for the patient.

Yet at the moment hope appeared, a slight jolt during bed transfer triggered another catastrophic hemorrhage. In the split second between life and death, Dr. Wang Jie Fu pressed down on the wound with the grip of an iron clamp.
In a storm of gushing blood, he remained motionless—a human hemostatic forceps—buying the surgical team invaluable time. After more than three hours of continuous manual compression, the surgery succeeded, and the covered stent was finally implanted.

An 18-Hour Battle Across Two Countries
When the life-threatening crisis was finally resolved, hearts across Guangzhou and Indonesia could at last relax. Behind this 18-hour rescue was the seamless coordination of the Interventional Department, ICU, Anesthesia Department, Procurement, and the translation team—an inspiring portrait of cross-department unity and courage.
And this was not an isolated case. Just last month, the same team carried out another nerve-wracking rescue: An Indonesian patient with an oral tumor suffered sudden massive bleeding, and all conventional hemostatic measures failed. In the moment of crisis, Dr. Wang Jie Fu once again stepped forward, manually pressing the bleeding point for more than two hours, creating a critical window for the interventional and anesthesia teams. After 45 minutes of coordinated effort, they successfully embolized the vessel and claimed another victory.

On This Battlefield Without Smoke and beneath the white coats lie not only superb medical skills, but shields of flesh and blood that protect life. Not only duty, but compassion—the resolve to guard life with life.

Click to learn more patient stories:
https://fudahospital.in/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in/

14/11/2025

[Patient Stories] [Sharing is Caring][Malaysia – Liver nodules – Interventional Chemo]

EP1: Companionship means a lot

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in

[Patient’s Story | Malaysia – Lung Cancer – Interventional Therapy]From Wheelchair to Walking Again: He Recovered from M...
12/11/2025

[Patient’s Story | Malaysia – Lung Cancer – Interventional Therapy]

From Wheelchair to Walking Again: He Recovered from Metastatic Lung Cancer in Just Three Months
Alifin (pseudonym), a farm owner from Malaysia, began suffering from unbearable headaches in May this year. When he went to the hospital for a checkup, the results were shocking — doctors discovered a 4.3 cm tumor in his brain. Further examination revealed that the real source of the problem was in his lungs: a malignant tumor (poorly differentiated adenocarcinoma) in the upper lobe of his left lung. The cancer had already spread to his brain, adrenal glands, and multiple lymph nodes in the neck and clavicle areas.

Alifin underwent brain tumor resection surgery at a local hospital, and postoperative pathology confirmed metastatic adenocarcinoma. However, the operation did not relieve his pain, and he had to rely on painkillers to get through each day. Just as his family was feeling desperate, a glimmer of hope appeared — Alifin’s sister got in touch with President Niu Lizhi of Guangzhou Fuda Cancer Hospital, who happened to be giving a lecture in Malaysia at the time.

When President Niu learned about his condition, Alifin was in very poor shape: his right face and neck were severely swollen, he suffered from constant neck pain, weakness in all limbs, and was unable to stand or take care of himself. After hearing that Guangzhou Fuda offered new treatment options different from traditional surgery, he decisively stopped all local treatments and flew to Guangzhou.

Upon his arrival, the scorching July heat of Guangzhou gave him a harsh welcome. Because of his neck pain, he desperately needed a cool environment, but the hot weather nearly drove him to collapse. As soon as he entered the hospital, he anxiously repeated, “It’s too hot!” Fortunately, his attending physician, Dr. Li Chunli, quickly brought him a small fan to help cool him down, gradually calming his nerves.

After a thorough examination and multidisciplinary consultation, the medical team confirmed the diagnosis: advanced lung cancer with systemic metastases, unsuitable for radical surgery. Moreover, his genetic test results suggested that single-agent targeted therapy or immunotherapy alone would likely have limited effectiveness.
Given the complex situation, Assistant Director Long Xin’an, Deputy Chief Physician Shi Juanjuan, and Attending Physician Li Chunli, among others, designed a personalized combination treatment plan:
Immunotherapy combined with intra-arterial infusion chemotherapy and right cervical tumor embolization.
This approach works like “precision-guided missiles,” delivering high concentrations of chemotherapy drugs directly to the tumor while stimulating the patient’s own immune system to attack cancer cells.

The treatment journey wasn’t without challenges. On the night after his first interventional procedure, Alifin suddenly suffered a seizure, a critical emergency. The medical, radiology, and neurosurgery teams responded immediately and determined that it was a complication related to his prior brain surgery. Thanks to prompt diagnosis and intervention, his condition was quickly stabilized, and he was able to continue his cancer therapy.
To better control the neck tumor and relieve pain, the team performed a neck tumor biopsy followed by radioactive iodine seed implantation — a precise form of internal radiotherapy.
This treatment is like planting tiny “micro atomic bombs” inside the tumor that continuously emit radiation to destroy cancer cells from within.

▲ “I am much better.”One month after the iodine seed implantation, Alifin returned for follow-up and told President Niu Lizhi excitedly that he felt much better.

Based on the latest pathology results, the team fine-tuned his interventional chemotherapy regimen for greater precision. After several cycles, his October review showed remarkable improvement:
The primary lung tumor and the metastatic lymph nodes in the neck, clavicle, and other parts of the body had all shrunk significantly.
Even better, his excruciating pain and limb weakness had greatly diminished — he could stand up again and walk on his own!

“Look! Look! I can walk by myself now!”
Alifin joyfully demonstrated his “new ability” to every doctor and nurse. With tears welling in his eyes, he grasped the nurses’ hands and said, voice trembling with emotion,

“Thank you… thank you for giving me my smile back.”
The image of his relieved, smiling face captures more than just personal recovery — it reflects the deep bond of compassion that transcends borders between doctors and patients.
Nurtured by trust and care, this flower of life has quietly blossomed — radiant and full of hope.

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in/

07/11/2025

[Minimally invasive treatment] [Melanoma – Cryoablation]

Melanoma with Multiple Metastases: Hydro-Isolation Makes Cryoablation Safer

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in/

31/10/2025

[Minimally invasive treatment] [Pancreatic Cancer – NanoKnife]

NanoKnife Precisely Ablates the “No-Go Zone” of Pancreatic Cancer Surgery

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in/

25/10/2025

[Minimally invasive treatment] [HongKong – Pancreatic Cancer – NanoKnife]

NanoKnife for Pancreatic Cancer with Liver Metastases

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in

21/10/2025

[Minimally invasive treatment] [China – Lung nodules – Cryoablation]

Intraoperative biopsy confirms lung cancer: elderly patient opts for cryoablation

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in/

10/10/2025

[Patient’s Stories] [China – Lung Cancer – Cryoablation]

Trusted by an Athlete with Late-stage Lung Cancer

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in/

30/09/2025

[Patient’s Story] [Hong Kong – Nasopharyngeal Carcinoma – Interventional Therapy]

Hong Kong Patient with Nasopharyngeal Carcinoma Rewrites His Fate at Fuda Cancer Hospital !

Click to learn more patient stories:
https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +86 15920523797
🌟 WhatsApp: +86 15920523797
🌍 Website: https://en.fudahospital.com/

Address

A-302, Rustomjee Central Park (Office Spaces), Andheri-Kurla Road, Opp. Kanakia Wall-Street, Andheri (East)
Mumbai
400093

Opening Hours

Monday 10:30am - 6pm
Tuesday 10:30am - 6pm
Wednesday 10:30am - 6pm
Thursday 10:30am - 6pm
Friday 10:30am - 6pm
Saturday 10:30am - 6pm

Telephone

+918850860970

Website

Alerts

Be the first to know and let us send you an email when Fuda Cancer Hospital - India posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Fuda Cancer Hospital - India:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

Fuda is committed to providing cancer patients around the world with the best medical care.

Fuda Cancer Hospital is considered one of the BEST cancer hospitals in China by patients and is affiliated to Jinan University and Translational Medicine Center of Guangzhou Institute of Biomedicine and Health of Chinese Academy of Sciences. As a tertiary hospital, Fuda operates with international standards and was selected as the National Key Clinical Specialty (Oncology) in 2010. In 2014, Fuda was accredited by the Joint Commission International (JCI), a golden standard of medical service worldwide. Fuda is equipped with 400 beds, 45 VIP rooms and 500 medical staffs to help our patients.

Cancer treatment varies from patient to patient. Multiple Disciplinary Teams work in Fuda to personalize treatment for every single patient. Those teams include NanoKnife Ablation team (Irreversible Electroporation), Cryosurgical ablation team, cancer micro-vascular intervention team, combined immunotherapy team, and surgical team. Our clinical achievement and academic research are widely accepted by peer doctors and scientific journals. In Fuda, Doctors use more than 20 types of cancer treatment, including those mentioned above, to help our patient LIVE WITH CANCER as long as possible with a quality life.

Fuda highly focuses on research and application of advanced clinical procedures and pays tremendous attention on patient care. In the past two decades, Fuda has been active in promoting Minimally Invasive Treatments such as Cryosurgery, NanoKnife, micro-vascular intervention treatment and Brachytherapy. Fuda was the first in China to introduce NanoKnife for clinical use and has accumulated substantial clinical experience. Patients are not just receiving treatment in Fuda, they live a life in Fuda with their family.